<scp>Epi‐miRNAs</scp> : Modern mediators of methylation status in human cancers-Reference-Cited by-同舟云学术

Epi‐miRNAs : Modern mediators of methylation status in human cancers

Published:2022-05-17 Issue:2 Volume:14 Page:
ISSN:1757-7004
Container-title:WIREs RNA
language:en
Short-container-title:WIREs RNA

Author:

Papadimitriou Maria‐Alexandra¹^ORCID,Panoutsopoulou Konstantina¹^ORCID,Pilala Katerina‐Marina¹^ORCID,Scorilas Andreas¹^ORCID,Avgeris Margaritis¹²^ORCID

Affiliation:

1. Department of Biochemistry and Molecular Biology, Faculty of Biology National and Kapodistrian University of Athens Athens Greece

2. Laboratory of Clinical Biochemistry ‐ Molecular Diagnostics, Second Department of Pediatrics School of Medicine, National and Kapodistrian University of Athens, “P. & A. Kyriakou” Children's Hospital Athens Greece

Publisher

Wiley

Subject

Molecular Biology,Biochemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/wrna.1735

Reference291 articles.

1. Whole blood microRNAs as potential biomarkers in post-operative early breast cancer patients

2. Early diagnostic evaluation of miR-122 and miR-224 as biomarkers for hepatocellular carcinoma

3. Ras-Induced miR-146a and 193a Target Jmjd6 to Regulate Melanoma Progression

4. miRNAs as Therapeutic Tools and Biomarkers for Prostate Cancer

5. The loss of the tumour-suppressor miR-145 results in the shorter disease-free survival of prostate cancer patients

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MIR145 Core Promoter Methylation in Pretreatment Cell-Free DNA: A Liquid Biopsy Tool for Muscle-Invasive Bladder Cancer Treatment Outcome;JCO Precision Oncology;2024-04

2. Drug resistance in ovarian cancer: from mechanism to clinical trial;Molecular Cancer;2024-03-28

3. Cancer quiescence: non-coding RNAs in the spotlight;Trends in Molecular Medicine;2023-10

4. Progress in the Understanding of Estrogen Receptor Alpha Signaling in Triple-Negative Breast Cancer: Reactivation of Silenced ER-α and Signaling through ER-α36;Molecular Cancer Research;2023-08-02

5. miRNA-seq identification and clinical validation of CD138+ and circulating miR-25 in treatment response of multiple myeloma;Journal of Translational Medicine;2023-04-06